The importance of angiogenic markers in the differential diagnosis of HELLP syndrome vs. non-HELLP thrombocytopenia

*Corresponding author: Francisco V. Álvarez Menéndez, Servicio de Bioquímica Clínica, Laboratorio de Medicina, Hospital Universitario Central de Asturias, Avda. Roma s/n – 33010 Oviedo. Spain, Phone: +34 985 10 80 75, E-mail: falvarezmen@gmail.com Covadonga Quirós, Francisco Suárez, Belén Prieto and Verónica Rodriguez: Servicio de Bioquímica Clínica, Laboratorio de Medicina, Hospital Universitario central de Asturias, Oviedo, Spain Óscar Vaquerizo: Servicio de Obstetricia y Ginecología, Hospital Universitario central de Asturias, Oviedo, Spain Letter to the Editor

[1]  T. Benzing,et al.  Removal of Soluble Fms-Like Tyrosine Kinase-1 by Dextran Sulfate Apheresis in Preeclampsia. , 2016, Journal of the American Society of Nephrology : JASN.

[2]  F. V. Álvarez,et al.  New biomarkers in diagnosis of early onset preeclampsia and imminent delivery prognosis , 2014, Clinical chemistry and laboratory medicine.

[3]  H. Zeisler,et al.  New Gestational Phase–Specific Cutoff Values for the Use of the Soluble fms-Like Tyrosine Kinase-1/Placental Growth Factor Ratio as a Diagnostic Test for Preeclampsia , 2014, Hypertension.

[4]  H. Stepan,et al.  The course of angiogenic factors in early- vs. late-onset preeclampsia and HELLP syndrome , 2013, Journal of perinatal medicine.

[5]  M. Glocker,et al.  Angiogenic factors and acute-phase proteins in serum samples of preeclampsia and HELLP patients: a matched-pair analysis , 2013, The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians.

[6]  K. Lim,et al.  Angiogenic Factors and the Risk of Adverse Outcomes in Women With Suspected Preeclampsia , 2012, Circulation.

[7]  I. Kovalszky,et al.  Microarray profiling reveals that placental transcriptomes of early-onset HELLP syndrome and preeclampsia are similar. , 2011, Placenta.

[8]  K. Lim,et al.  The use of angiogenic biomarkers to differentiate non-HELLP related thrombocytopenia from HELLP syndrome , 2010, The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians.

[9]  L. Smits,et al.  Clinical differences between early-onset HELLP syndrome and early-onset preeclampsia during pregnancy and at least 6 months postpartum. , 2010, American journal of obstetrics and gynecology.

[10]  M. Lindheimer,et al.  Explaining and predicting preeclampsia. , 2006, The New England journal of medicine.

[11]  B. Sibai.  HIGH-RISK PREGNANCY SERIES: AN EXPERT’S VIEW Diagnosis, Controversies, and Management of the Syndrome of Hemolysis, Elevated Liver Enzymes, and Low Platelet Count , 2004 .